CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
    P.-A. Westerberg, T. Linde, D. Vanderschueren, J. Billen, I. Jans, and O. Ljunggren
    Clinical Kidney Journal (2012) 5 :240
  • Fibroblast growth factor 23 and bone mineralisation
    Yu-Chen Guo and Quan Yuan
    International Journal of Oral Science (2015) 7 :8
  • Rickets
    M. Zulf Mughal
    Current Osteoporosis Reports (2011) 9 :291
  • Proximal tibial pain in a child
    Eric R. Henderson, Christina M. Jacobsen, Rebecca A. Pohlmann, Harry P. W. Kozakewich, Ingrid A. Holm, and Mark C. Gebhardt
    Skeletal Radiology (2013) 42 :1333
  • Identification of a novel loss-of-function PHEX mutation, Ala720Ser, in a sporadic case of adult-onset hypophosphatemic osteomalacia
    Katarzyna Goljanek-Whysall, Andreas Tridimas, Rachel McCormick, Nicki-Jayne Russell, Melissa Sloman, Alan Sorani, William D. Fraser, and Fadil M. Hannan
    Bone (2017) :
  • Osteomalacia tumoral: un síndrome paraneoplásico emergente
    Guillermo Alonso and Mariela Varsavsky
    Endocrinología y Nutrición (2016) 63 :181
  • 1,25-Dihydroxyvitamin D3 Regulation of Fibroblast Growth Factor-23 Expression in Bone Cells: Evidence for Primary and Secondary Mechanisms Modulated by Leptin and Interleukin-6
    Rimpi K. Saini, Ichiro Kaneko, Peter W. Jurutka, Ryan Forster, Antony Hsieh, Jui-Cheng Hsieh, Mark R. Haussler, and G. Kerr Whitfield
    Calcified Tissue International (2013) 92 :339
  • ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors
    Shogo Tajima, Yuichi Takashi, Nobuaki Ito, Seiji Fukumoto, and Masashi Fukuyama
    Medical Molecular Morphology (2016) 49 :203
  • Increased Col10a1 expression is not causative for the phenotype of Phex-deficient Hyp mice
    Timur Yorgan, Carsten Rendenbach, Anke Jeschke, Michael Amling, Kathryn S.E. Cheah, and Thorsten Schinke
    Biochemical and Biophysical Research Communications (2013) 442 :209
  • Tumor-induced osteomalacia: experience from a South American academic center
    G. González, R. Baudrand, M. F. Sepúlveda, N. Vucetich, F. J. Guarda, P. Villanueva, O. Contreras, A. Villa, F. Salech, L. Toro, L. Michea, and P. Florenzano
    Osteoporosis International (2017) 28 :2187
  • Diabètes phosphatés
    Véronique Breuil and Liana Euller-Ziegler
    Revue du Rhumatisme Monographies (2012) 79 :253
  • Oncogenic Osteomalacia Caused by Phosphaturie Mesenchymal Tumours in the Proximal and Shaft of the Tibia: A Case Report
    Kongkit Pithankuakul, Tanaporn Ratanasuwan, Voranuch Thanakit, Bhasanan Sukhantanak, and Piya Kiatisevi
    Journal of Orthopaedic Surgery (2014) 22 :257
  • The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases
    Juan Feng, Yan Jiang, Ou Wang, Mei Li, Xiaoping Xing, Li Huo, Fang Li, Wei Yu, Ding-rong Zhong, Jin Jin, Yong Liu, Fang Qi, Wei Lv, Lian Zhou, Xun-wu Meng, and Wei-bo Xia
    Endocrine Journal (2017) 64 :675
  • Treatment of Hypophosphatemic Rickets with Phosphate and Active Vitamin D in Japan: A Questionnaire-based Survey
    Makoto Fujiwara, Noriyuki Namba, Keiichi Ozono, Osamu Arisaka, and Susumu Yokoya
    Clinical Pediatric Endocrinology (2013) 22 :9
  • Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome
    Mary Scott Ramnitz, Pravitt Gourh, Raphaela Goldbach-Mansky, Felasfa Wodajo, Shoji Ichikawa, Michael J Econs, Kenneth E White, Alfredo Molinolo, Marcus Y Chen, Theo Heller, Jaydira Del Rivero, Patricia Seo-Mayer, Bita Arabshahi, Malaka B Jackson, Sarah Hatab, Edward McCarthy, Lori C Guthrie, Beth A Brillante, Rachel I Gafni, and Michael T Collins
    Journal of Bone and Mineral Research (2016) 31 :1845
  • Paraneoplastic rheumatologic syndromes
    Lama Azar and Atul Khasnis
    Current Opinion in Rheumatology (2013) 25 :44
  • pH Sensing Properties of Flexible, Bias-Free Graphene Microelectrodes in Complex Fluids: From Phosphate Buffer Solution to Human Serum
    Jinglei Ping, Jacquelyn E. Blum, Ramya Vishnubhotla, Amey Vrudhula, Carl H. Naylor, Zhaoli Gao, Jeffery G. Saven, and Alan T. Charlie Johnson
    Small (2017) 13 :1700564
  • Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23
    Ji-Yeon Lee, Hye-Sun Park, Seunghee Han, Jiyu Kelly Lim, Namki Hong, Sung Il Park, and Yumie Rhee
    Yonsei Medical Journal (2017) 58 :981
  • Insufficiency Fracture Associated With Oncogenic Osteomalaciar
    Thomas Niemeier, Lee Leddy, Marcy Bolster, and Russell Chapin
    JCR: Journal of Clinical Rheumatology (2013) :1
  • The Foot That Broke Both Hips: A Case Report and Literature Review of Tumor-Induced Osteomalacia
    Sara Beygi, Alfred Denio, and Tarun S. Sharma
    Case Reports in Rheumatology (2017) 2017 :1
  • A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia
    Ryuta Arai, Tomohiro Onodera, Mohamad Alaa Terkawi, Tomoko Mitsuhashi, Eiji Kondo, and Norimasa Iwasaki
    BMC Musculoskeletal Disorders (2017) 18 :
  • Oncogenic osteomalacia — Hypophosphataemic spectrum from “benignancy” to “malignancy”
    P. Chiam, H.C. Tan, Y.M. Bee, and M. Chandran
    Bone (2013) 53 :182
  • Osteomalacia-Inducing Renal Clear Cell Carcinoma Uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-Octreotide (99mTc-HYNIC-TOC) Scintigraphy
    Xiaona Jin, Hongli Jing, Fang Li, and Hongming Zhuang
    Clinical Nuclear Medicine (2013) 38 :922
  • Association of serum intact fibroblast growth factor 23 with left ventricular mass and different echocardiographic findings in patients on hemodialysis
    Amir Ahmad Nassiri, Monir Sadat Hakemi, Reza Safar-Pour, Ali Ahmadi, Maryam Tohidi, Babak Sharif Kashani, Fatemeh Esfehani, and Soudabeh Alatab
    Journal of Translational Internal Medicine (2016) 4 :
  • Musculoskeletal oncogenic osteomalacia–An experience from a single centre in South India
    Anil Satyaraddi, Kripa Elizabeth Cherian, Sahana Shetty, Nitin Kapoor, Felix K Jebasingh, Vinoo Mathew Cherian, Julie Hephzibah, Anne Jennifer Prabhu, Nihal Thomas, and Thomas V Paul
    Journal of Orthopaedics (2017) 14 :184
  • Electrolyte Disorders Associated With Cancer
    Mitchell H. Rosner and Alan C. Dalkin
    Advances in Chronic Kidney Disease (2014) 21 :7
  • Painful losses
    David H. Wesorick, Daniel J. Brotman, Craig Jaffe, Aaron Berg, May P. Chan, and Nathan Houchens
    Journal of Hospital Medicine (2016) 11 :730
  • Oncogenic hypophosphatemic osteomalacia: From the first signal of disease to the first signal of healthy
    Arthur Paredes Gatti, Luiza Tonello, João Alfredo Diedrich Neto, Uirá Fernandes Teixeira, Marcos Bertozzi Goldoni, Paulo Roberto Ott Fontes, José Artur Sampaio, Luiz Maraninchi Pereira Lima, and Fábio Luiz Waechter
    International Journal of Surgery Case Reports (2017) 30 :130
  • Coexistence of Tumor-Induced Osteomalacia and Primary Hyperparathyroidism
    Athina Markou, Vassiliki Tsiama, Symeon Tournis, Labrini Papanastasiou, Vaios Tsiavos, Aikaterini Dassou, Vasiliki Vlachou, Eugenia Papaliodi, Niki Asimaki, George Zografos, and George Piaditis
    Endocrine Practice (2011) 17 :e144
  • Insights From Genetic Disorders of Phosphate Homeostasis
    Marta Christov and Harald Jüppner
    Seminars in Nephrology (2013) 33 :143
  • Soluble klotho may be a marker of phosphate reabsorption
    Sven-Jean Tan, Edward R. Smith, Stephen G. Holt, Tim D. Hewitson, and Nigel D. Toussaint
    Clinical Kidney Journal (2017) 10 :397
  • Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia
    Fuminori Tatsumi, Megumi Horiya, Akihito Tanabe, Momoyo Nishioka, Yoshiro Fushimi, Junpei Sanada, Yurie Hirata, Shintaro Irie, Tomoe Kinoshita, Shinji Kamei, Masashi Shimoda, Tomoatsu Mune, Kohei Kaku, and Hideaki Kaneto
    SpringerPlus (2016) 5 :
  • Effects of Extracellular Phosphate on Gene Expression in Murine Osteoblasts
    C. Rendenbach, T. A. Yorgan, T. Heckt, B. Otto, C. Baldauf, A. Jeschke, T. Streichert, J. P. David, M. Amling, and T. Schinke
    Calcified Tissue International (2014) 94 :474
  • Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET/CT vs somatostatin receptor-based functional scans: a series of nine patients
    Swati Jadhav, Rajeev Kasaliwal, Vikram Lele, Venkatesh Rangarajan, Piyush Chandra, Hina Shah, Gaurav Malhotra, Varsha S. Jagtap, Sweta Budyal, Anurag R. Lila, Tushar Bandgar, and Nalini S. Shah
    Clinical Endocrinology (2014) 81 :31
  • Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma
    Mathilde M. Bruins Slot-Steenks, Neveen A.T. Hamdy, Michiel A.J. van de Sande, Dennis Vriens, Arjen H.G. Cleven, and Natasha M. Appelman-Dijkstra
    Endocrine (2016) 54 :642
  • Total hip/knee arthroplasty in the treatment of tumor-induced osteomalacia patients: More than 1 year follow-up
    Wei Zhu, Qi Ma, Yanyan Bian, Qianyu Zhuang, Zenan Xia, Jin Jin, Xisheng Weng, and Chunfeng Zhao
    PLOS ONE (2017) 12 :e0177835
  • Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype
    Nobuhiro Kamiya, Ryosuke Yamaguchi, Olumide Aruwajoye, Audrey J Kim, Gen Kuroyanagi, Matthew Phipps, Naga Suresh Adapala, Jian Q Feng, and Harry KW Kim
    Journal of Bone and Mineral Research (2017) 32 :1716
  • Tumour-induced osteomalacia: An emergent paraneoplastic syndrome
    Guillermo Alonso and Mariela Varsavsky
    Endocrinología y Nutrición (English Edition) (2016) 63 :181
  • Ostéomalacie secondaire à une tumeur mésenchymateuse phosphaturique de révélation tardive
    T. Chazal, V. Khanine, O. Lidove, S. Godot, and J.-M. Ziza
    La Revue de Médecine Interne (2017) 38 :412
  • Malignant phosphaturic mesenchymal tumor with pulmonary metastasis
    Shui Qiu, Li-Li Cao, Yue Qiu, Ping Yan, Zi-xuan Li, Jiang Du, Li-Mei Sun, and Qing-Fu Zhang
    Medicine (2017) 96 :e6750
  • 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT
    Stefan Breer, Thomas Brunkhorst, F. Timo Beil, Kersten Peldschus, Max Heiland, Susanne Klutmann, Florian Barvencik, Jozef Zustin, Klaus-Friedrich Gratz, and Michael Amling
    Bone (2014) 64 :222
  • Rarely metastasizing soft tissue tumours
    D Chas Mangham and Lars-Gunnar Kindblom
    Histopathology (2014) 64 :88
  • Rheumatologic Manifestations of Malignancy
    Mandana Hashefi
    Clinics in Geriatric Medicine (2017) 33 :73
  • Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
    Anke H. Hautmann, Josef Schroeder, Peter Wild, Matthias G. Hautmann, Elisabeth Huber, Patrick Hoffstetter, Martin Fleck, and Christiane Girlich
    Case Reports in Endocrinology (2014) 2014 :1
  • Osteomalacia by a mesenchymal-FGF23-producing tumour: Successful treatment with radiofrequency ablation. A case report
    Annette Igney-Oertel, Ferruh Artunc, Jörg Henes, Ruediger Hoffmann, and Stephan Clasen
    Joint Bone Spine (2016) 83 :603
  • Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors
    Zhi-jian Sun, Jin Jin, Gui-xing Qiu, Peng Gao, and Yong Liu
    BMC Musculoskeletal Disorders (2015) 16 :
  • Ga68-DOTA Peptide PET/CT to Detect Occult Mesenchymal Tumor-Inducing Osteomalacia: A Case Series of Three Patients
    Chi Long Ho
    Nuclear Medicine and Molecular Imaging (2015) 49 :231
  • Ostéomalacie provoquée par une tumeur mésenchymateuse productrice de FGF23 : ablation par radiofréquence suivie de guérison
    Annette Igney-Oertel, Ferruh Artunc, Jörg Henes, Ruediger Hoffmann, and Stephan Clasen
    Revue du Rhumatisme (2017) 84 :361
  • Tumor-induced osteomalacia
    Pablo Florenzano, Rachel I. Gafni, and Michael T. Collins
    Bone Reports (2017) 7 :90
  • Rheumatic Manifestations of Primary and Metastatic Bone Tumors and Paraneoplastic Bone Disease
    Christian A. Waimann, Huifang Lu, and Maria E. Suarez Almazor
    Rheumatic Disease Clinics of North America (2011) 37 :527
  • MicroRNA expression in a phosphaturic mesenchymal tumour
    Darrell Green, Irina Mohorianu, Isabelle Piec, Jeremy Turner, Clare Beadsmoore, Andoni Toms, Richard Ball, John Nolan, Iain McNamara, Tamas Dalmay, and William D. Fraser
    Bone Reports (2017) 7 :63
  • FGF23 associated bone diseases
    Eryuan Liao
    Frontiers of Medicine (2013) 7 :65
  • Tumour-induced osteomalacia: a literature review and a case report
    Jolanta Dadoniene, Marius Miglinas, Dalia Miltiniene, Donatas Vajauskas, Dmitrij Seinin, Petras Butenas, and Tomas Kacergius
    World Journal of Surgical Oncology (2015) 14 :
  • A Novel Chromogenic In Situ Hybridization Assay for FGF23 mRNA in Phosphaturic Mesenchymal Tumors
    Jodi M. Carter, Bolette L. Caron, Ahmet Dogan, and Andrew L. Folpe
    The American Journal of Surgical Pathology (2015) 39 :75
  • Genetic diseases resulting from disordered FGF23/klotho biology
    Michael J. Econs
    Bone (2017) 100 :56
  • Multimodality Image-Guided Cryoablation for Inoperable Tumor-Induced Osteomalacia
    Sri Harsha Tella, Hayet Amalou, Bradford J Wood, Richard Chang, Clara C Chen, Cemre Robinson, Michelle Millwood, Lori C Guthrie, Sheng Xu, Elliot Levy, Venkatesh Krishnasamy, Rachel I Gafni, and Michael T Collins
    Journal of Bone and Mineral Research (2017) :
  • Tumor localization and biochemical response to cure in tumor-induced osteomalacia
    William H Chong, Panagiota Andreopoulou, Clara C Chen, James Reynolds, Lori Guthrie, Marilyn Kelly, Rachel I Gafni, Nisan Bhattacharyya, Alison M Boyce, Diala El-Maouche, Diana Ovejero Crespo, Richard Sherry, Richard Chang, Felasfa M Wodajo, Gad B Kletter, Andrew Dwyer, and Michael T Collins
    Journal of Bone and Mineral Research (2013) 28 :1386
  • Fibrous Dysplasia and Fibroblast Growth Factor-23 Regulation
    Alison M. Boyce, Nisan Bhattacharyya, and Michael T. Collins
    Current Osteoporosis Reports (2013) 11 :65
  • The PTH-Vitamin D-FGF23 axis
    Jenny E. Blau and Michael T. Collins
    Reviews in Endocrine and Metabolic Disorders (2015) 16 :165
  • Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients
    Michishige Ozeki, Shu-ichi Fujita, Shun Kizawa, Hideaki Morita, Koichi Sohmiya, Masaaki Hoshiga, and Nobukazu Ishizaka
    BMC Nephrology (2014) 15 :
  • Tumor-Induced Rickets Presenting in an Adolescent
    Nathan T. Morrell, Nancy L. Beck, Carol Clericuzio, Carmen Frias-Kletecka, and Elizabeth A. Szalay
    JBJS Case Connector (2014) 4 :e79
  • Tumor-induced osteomalacia caused by phosphaturic mesenchymal tumor of the cervical spine
    Takeshi Nakamura, Toshimi Aizawa, Hiroshi Ozawa, Eiji Itoi, Takeshi Hoshikawa, Nobuaki Ito, Seiji Fukumoto, and Shoichi Kokubun
    Journal of Orthopaedic Science (2015) 20 :765
  • An unusual treatable cause for proximal muscle weakness
    S. Shetty, N. Kapoor, V. M. Cherian, and T. V. Paul
    Case Reports (2015) 2015 :bcr2014208731
  • Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia
    Meghan Higley, Brooke Beckett, Sandra Schmahmann, Elizabeth Dacey, and Erik Foss
    Skeletal Radiology (2015) 44 :1825
  • Expression of fibroblast growth factor 23 by canine soft tissue sarcomas
    M. R. Hardcastle and K. E. Dittmer
    Veterinary and Comparative Oncology (2016) 14 :306
  • Paraneoplastic syndromes in rheumatology
    Bernhard Manger and Georg Schett
    Nature Reviews Rheumatology (2014) 10 :662
  • Imaging of Osteoporosis
    Robert Schneider
    Rheumatic Disease Clinics of North America (2013) 39 :609
  • The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia
    Qian Zhang, Michele Doucet, Ryan E Tomlinson, Xiaobin Han, L Darryl Quarles, Michael T Collins, and Thomas L Clemens
    Bone Research (2016) 4 :16011
  • Reports of 17 Chinese patients with tumor-induced osteomalacia
    Wei-Jia Yu, Jin-Wei He, Wen-Zhen Fu, Chun Wang, and Zhen-Lin Zhang
    Journal of Bone and Mineral Metabolism (2017) 35 :298
  • Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia
    Sophia Hu, Seena C. Aisner, and Sara E. Lubitz
    AACE Clinical Case Reports (2015) 1 :e225
  • Tumor-associated FGF-23-induced hypophosphatemic rickets in children: a case report and review of the literature
    Marie-Anne Burckhardt, Alexandra Schifferli, Andreas H. Krieg, Daniel Baumhoer, Gabor Szinnai, and Christoph Rudin
    Pediatric Nephrology (2015) 30 :179
  • The expanding family of hypophosphatemic syndromes
    Thomas O. Carpenter
    Journal of Bone and Mineral Metabolism (2012) 30 :1
  • Tumor-induced osteomalacia: An important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature
    Yan Jiang, Wei-bo Xia, Xiao-ping Xing, Barbara C Silva, Mei Li, Ou Wang, Hua-bing Zhang, Fang Li, Hong-li Jing, Ding-rong Zhong, Jin Jin, Peng Gao, Lian Zhou, Fang Qi, Wei Yu, John P Bilezikian, and Xun-wu Meng
    Journal of Bone and Mineral Research (2012) 27 :1967
  • Hypophosphatemic Rickets: Unraveling the Role of FGF23
    John M. Pettifor and Kebashni Thandrayen
    Calcified Tissue International (2012) 91 :297
  • The role of intestinal alkaline phosphatase in pediatric inflammatory bowel and celiac diseases
    Kriszta Molnár, Ádám Vannay, Erna Sziksz, Nóra Fanni Bánki, Áron Cseh, Hajnalka Győrffy, Antal Dezsőfi, András Arató, and Gábor Veres
    Orvosi Hetilap (2012) 153 :1389
  • Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature
    Ramy H. Bishay, Kirtan Ganda, and Markus J. Seibel
    Therapeutic Advances in Endocrinology and Metabolism (2017) 8 :14
  • Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution
    Taichi Yoshida, Daiki Taguchi, Koji Fukuda, Kazuhiro Shimazu, Masahiro Inoue, Katsunori Murata, and Hiroyuki Shibata
    International Journal of Clinical Oncology (2017) 22 :244
  • Fibroblast growth factor 23: state of the field and future directions
    Nisan Bhattacharyya, William H. Chong, Rachel I. Gafni, and Michael T. Collins
    Trends in Endocrinology & Metabolism (2012) 23 :610
  • FGF23: Mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?
    Esther K. Lee, Maria Carmen Riesco Martinez, Kim Blakely, Keemo Delos Santos, Van C. Hoang, Annabelle Chow, and Urban Emmenegger
    Medical Hypotheses (2014) 83 :482
  • Bone pain, muscle weakness and gait abnormalities in a 57-year-old woman: tumor induced osteomalacia
    Giorgia Fornelli, Patrizia D’Amelio, Paolo Rossi, and Giancarlo Isaia
    Research (2014) 1 :
  • En Bloc Resection of Solitary Functional Secreting Spinal Metastasis
    C. Rory Goodwin, Michelle J. Clarke, Ziya L. Gokaslan, Charles Fisher, Ilya Laufer, Michael H. Weber, and Daniel M. Sciubba
    Global Spine Journal (2016) 6 :277
  • Relationship between timed and spot urine collections for measuring phosphate excretion
    Sven-Jean Tan, Edward R. Smith, Michael M. X. Cai, Stephen G. Holt, Tim D. Hewitson, and Nigel D. Toussaint
    International Urology and Nephrology (2016) 48 :115
  • Is there any link between tumor-induced osteomalacia and psoriasis? A case report
    Mojtaba Akbari, Bagher Larijani, Sasan Sharghi, Ali Jalili, and Sayed Mahmoud Sajjadi-Jazi
    Journal of Diabetes & Metabolic Disorders (2017) 16 :
  • Effects of phospho- and calciotropic hormones on electrolyte transport in the proximal tubule
    Justin J. Lee, Allein Plain, Megan R. Beggs, Henrik Dimke, and R. Todd Alexander
    F1000Research (2017) 6 :1797
  • Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones
    Hai Wang, Dingrong Zhong, Yong Liu, Yan Jiang, Guixing Qiu, Xisheng Weng, Xiaoping Xing, Mei Li, Xunwu Meng, Fang Li, Zhaohui Zhu, Wei Yu, Weibo Xia, and Jin Jin
    The Journal of Bone and Joint Surgery (2015) 97 :1084
  • Tumor-Induced Osteomalacia Resulting from Primary Cutaneous Phosphaturic Mesenchymal Tumor: A Case and Review of the Medical Literature
    Kevin H. Gardner, Wonwoo Shon, Andrew L. Folpe, Carilyn N. Wieland, Peter J. Tebben, and Christian L. Baum
    Journal of Cutaneous Pathology (2013) 40 :780
  • Tumor-induced osteomalacia caused by a massive phosphaturic mesenchymal tumor of the acetabulum: A case report
    Kimitaka Nakamura, Masanobu Ohishi, Tomoya Matsunobu, Yasuharu Nakashima, Akio Sakamoto, Akira Maekawa, Yoshinao Oda, and Yukihide Iwamoto
    Modern Rheumatology (2016) :1
  • Tumor-Induced Osteomalacia: an Up-to-Date Review
    Anke H. Hautmann, Matthias G. Hautmann, Oliver Kölbl, Wolfgang Herr, and Martin Fleck
    Current Rheumatology Reports (2015) 17 :
  • FGF23 Producing Mesenchymal Tumor
    Lucyna Papierska, Jarosław B. Ćwikła, Waldemar Misiorowski, Michał Rabijewski, Krzysztof Sikora, and Hubert Wanyura
    Case Reports in Endocrinology (2014) 2014 :1
  • VISUAL VIGNETTE
    Gayatri Kuraganti, René J. Harper, Darko Pucar, Kelly C. Homlar, and Hadyn T. Williams
    Endocrine Practice (2016) 22 :1361
  • Protocolo diagnóstico de la osteomalacia
    M. Partida, E. García, and G. Martínez Díaz-Guerra
    Medicine - Programa de Formación Médica Continuada Acreditado (2012) 11 :985
  • Phosphate wasting and fibroblast growth factor-23
    Mark S. Nanes
    Current Opinion in Endocrinology & Diabetes and Obesity (2013) 20 :523
  • Tumour-induced osteomalacia
    Salvatore Minisola, Munro Peacock, Seijii Fukumoto, Cristiana Cipriani, Jessica Pepe, Sri Harsha Tella, and Michael T. Collins
    Nature Reviews Disease Primers (2017) 3 :17044
  • Phosphaturic mesenchymal tumor: two contrasting cases
    Monica C. Koplas, Brian P. Rubin, and Murali Sundaram
    Skeletal Radiology (2014) 43 :841
  • Octreotide Is Ineffective in Treating Tumor-Induced Osteomalacia: Results of a Short-Term Therapy
    Diana Ovejero, Diala El-Maouche, Beth A Brillante, Azar Khosravi, Rachel I Gafni, and Michael T Collins
    Journal of Bone and Mineral Research (2017) 32 :1667
  • Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
    Bryan Oronsky, Scott Caroen, Arnold Oronsky, Vaughn E. Dobalian, Neil Oronsky, Michelle Lybeck, Tony R. Reid, and Corey A. Carter
    Cancer Chemotherapy and Pharmacology (2017) :
  • FGF23-Associated Tumor-Induced Osteomalacia in a Patient With Small Cell Carcinoma
    Adrienne Sauder, Szymon Wiernek, Xumin Dai, Renata Pereira, Michael Yudd, Charvi Patel, Andrew Golden, Shahida Ahmed, Jin Choe, Victor Chang, Slawomir Sender, and Donghong Cai
    International Journal of Surgical Pathology (2016) 24 :116
  • From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses
    Yingting Mok, Jen-chieh Lee, Jeffrey Huey Yew Lum, and Fredrik Petersson
    Histopathology (2016) 68 :925
  • Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition
    Milena Perez Mak, Verônica Torres da Costa e Silva, Regina Matsunaga Martin, Antonio Marcondes Lerario, Luis Yu, Paulo Marcelo Gehm Hoff, and Gilberto de Castro Junior
    Supportive Care in Cancer (2012) 20 :2195
  • Whole-Body 99mTc-Octreotide Scintigraphy With SPECT/CT to Detect Occult Tumor Inducing Paraneoplastic Osteomalacia
    Napoleão Ramalho Rodrigues, Ana Luisa Calich, Mauricio Etchebehere, Wilson Andre Ichiki, Fabio Payao Pereira, Elaine Maria Ingrid Amstalden, and Elba Cristina de Sa Etchebehere
    Clinical Nuclear Medicine (2015) 40 :54
  • Tumor-Induced Osteomalacia Secondary to a Fibroblast Growth Factor 23-Secreting Phosphaturic Mesenchymal Tumor in the Foot
    Yuhree Kim, Emily Stein, Fabrizio Remotti, and Francis Y. Lee
    JBJS Case Connector (2014) 4 :e22
  • Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis
    Bracha K. Goldsweig and Thomas O. Carpenter
    Current Osteoporosis Reports (2015) 13 :88
  • Phosphaturic mesenchymal tumour in the temporal bone – A rare presentation
    Gaurav Ashish, John Mathew, Nihal Thomas, Nitin Kapoor, and S. Elanthenral
    Egyptian Journal of Ear, Nose, Throat and Allied Sciences (2014) 15 :149
  • Tumor-Induced Osteomalacia Caused by Primary Fibroblast Growth Factor 23 Secreting Neoplasm in Axial Skeleton: A Case Report
    Gunjan Y. Gandhi, Aashish A. Shah, Kevin J. Wu, Vivek Gupta, and Ali Reza Shoraka
    Case Reports in Endocrinology (2012) 2012 :1
  • Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions
    Stephanie S. Crossen, Eduardo Zambrano, Beverley Newman, Jonathan A. Bernstein, Anna H. Messner, Laura K. Bachrach, and Clare J. Twist
    Journal of Pediatric Hematology/Oncology (2017) 39 :e21
  • The Phosphaturic Mesenchymal Tumor: Why is Definitive Diagnosis and Curative Surgery Often Delayed?
    Cameron K. Ledford, Nicole A. Zelenski, Diana M. Cardona, Brian E. Brigman, and William C. Eward
    Clinical Orthopaedics and Related Research® (2013) 471 :3618
  • Striking Pathology Gold: A Singular Experience with Daily Reverberations: Sinonasal Hemangiopericytoma (Glomangiopericytoma) and Oncogenic Osteomalacia
    Margaret Brandwein-Gensler and Gene P. Siegal
    Head and Neck Pathology (2012) 6 :64